Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.22B |
| 2 |
Alibaba
BABA
|
+$408M |
| 3 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$292M |
| 4 |
Gilead Sciences
GILD
|
+$218M |
| 5 |
Ford
F
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.37B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.18B |
| 3 |
YHOO
Yahoo Inc
YHOO
|
+$619M |
| 4 |
Bank of America
BAC
|
+$487M |
| 5 |
Booking.com
BKNG
|
+$406M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.53% |
| 2 | Consumer Discretionary | 2.02% |
| 3 | Financials | 1.63% |
| 4 | Healthcare | 1.38% |
| 5 | Energy | 1.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
PUT
Workday
WDAY
$49.2B
| $46.8M | 0.02% |
573,400
-133,800
| -19% | -$11.6M |
|
752
CALL
Thermo Fisher Scientific
TMO
$232B
| $46.6M | 0.02% |
372,300
+30,000
| +9% | +$3.65M |
|
753
PUT
Wheaton Precious Metals
WPM
$72.8B
| $46.6M | 0.02% |
2,293,600
-581,700
| -20% | -$11.6M |
|
754
PUT
ProShares UltraPro QQQ
TQQQ
$34.7B
| $46.5M | 0.02% |
22,915,200
-2,865,600
| -11% | -$5.49M |
|
|
CHL
755
CALL
DELISTED
China Mobile Limited
CHL
| $46.4M | 0.02% |
788,100
+141,600
| +22% | +$8.48M |
|
756
PUT
F5
FFIV
$21.5B
| $46.2M | 0.02% |
354,100
-47,700
| -12% | -$5.95M |
|
757
CALL
Carnival Corporation Ltd
CCL
$35.2B
| $46.1M | 0.02% |
1,017,700
+89,000
| +10% | +$3.64M |
|
|
KRFT
758
PUT
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
| $46.1M | 0.02% |
735,500
+290,700
| +65% | +$17M |
|
759
PUT
CVS Health
CVS
$120B
| $46M | 0.02% |
477,800
-78,700
| -14% | -$6.93M |
|
|
MWV
760
CALL
DELISTED
MEADWESTVACO CORP
MWV
| $46M | 0.02% |
1,036,500
+934,800
| +919% | +$40.5M |
|
761
PUT
Stanley Black & Decker
SWK
$14.9B
| $45.9M | 0.02% |
478,100
+118,400
| +33% | +$10.9M |
|
|
ESV
762
PUT
DELISTED
Ensco Rowan plc
ESV
| $45.8M | 0.02% |
382,075
-45,400
| -11% | -$6.51M |
|
763
CALL
Molson Coors Class B
TAP
$8.02B
| $45.8M | 0.02% |
614,200
-208,200
| -25% | -$15.4M |
|
764
CALL
Truist Financial
TFC
$62.1B
| $45.7M | 0.02% |
1,175,800
-153,300
| -12% | -$5.77M |
|
765
Oracle
ORCL
$410B
| $45.7M | 0.02% |
1,016,073
-303,370
| -23% | -$12.3M |
|
766
CALL
State Street SPDR S&P Biotech ETF
XBI
$11.5B
| $45.7M | 0.02% |
733,800
+15,600
| +2% | +$889K |
|
|
BEAV
767
PUT
DELISTED
B/E Aerospace Inc
BEAV
| $45.6M | 0.02% |
786,400
-144,256
| -16% | -$8.04M |
|
768
PUT
D.R. Horton
DHI
$41.7B
| $45.5M | 0.02% |
1,799,500
-20,100
| -1% | -$470K |
|
769
Merck
MRK
$372B
| $45.5M | 0.02% |
839,611
+334,437
| +66% | +$18.6M |
|
|
BNY
770
CALL
Bank of New York Mellon
BNY
$110B
| $45.5M | 0.02% |
1,120,800
+181,300
| +19% | +$7.09M |
|
771
CALL
McKesson
MCK
$102B
| $45.4M | 0.02% |
218,900
-39,500
| -15% | -$8.02M |
|
|
P
772
CALL
DELISTED
Pandora Media Inc
P
| $45.4M | 0.02% |
2,546,800
+84,400
| +3% | +$1.67M |
|
773
Caterpillar
CAT
$373B
| $45.3M | 0.02% |
494,658
-320,129
| -39% | -$31.2M |
|
|
BBBY
774
PUT
DELISTED
Bed Bath & Beyond Inc
BBBY
| $45.3M | 0.02% |
594,100
-416,500
| -41% | -$29.1M |
|
775
CALL
CNX Resources
CNX
$5.4B
| $45.2M | 0.02% |
1,602,600
+564,480
| +54% | +$17.1M |
|
Similar funds
Jeff Yass's Q4 2014 Portfolio in Review
As of Q4 2014, Jeff Yass held 10,737 positions worth $252B, down 3% from $260B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Jeff Yass withdrew a net $10.2B in Q4 2014, closing 1,178 positions and reducing 4,352 holdings. Its most notable exit was Bausch Health, an estimated $68.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 2.5% of assets, up from 2.2% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jeff Yass opened a new position in Northern Trust Morningstar Global Upstream Natural Resources ETF worth $31M.
- Jeff Yass's largest Q4 2014 buy was Northern Trust Morningstar Global Upstream Natural Resources ETF: 1,011,289 shares worth $31M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q4 2014, an estimated $1.22B increase.
- Jeff Yass's biggest Q4 2014 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $1.37B.
- Jeff Yass fully exited Bausch Health in Q4 2014, selling an estimated $68.9M.
- Jeff Yass's ten largest holdings make up 23% of its $252B portfolio in Q4 2014.
- Jeff Yass opened 1,370 new positions and closed 1,178 in Q4 2014.
- Jeff Yass's portfolio value fell 3% quarter-over-quarter to $252B.
Based on Susquehanna International Group's 13F filing for Q4 2014, filed 17 Feb 2015.